Disorders of Lipid Metabolism and its Correction in Chronic Kidney Disease
Journal Title: Нирки - Year 2016, Vol 2, Issue 16
Abstract
Chronic kidney disease — a proven risk factor of the development and progression of lipid metabolism disorders. The basis of these disorders — an increase in blood plasma cholesterol, triglycerides, low density lipoproteins and decreased levels of high density lipoproteins, apo AI and apo AII. There has been a decrease in the activity of enzymes: lipoprotein lipase, hepatic triglyceride lipase, lecithin-cholesterol acyltransferase. The use of lipid-modifying drugs — statins, fibrates, nicotinic acid was proposed.
Authors and Affiliations
O. O. Melnyk
Keywords
Related Articles
- EP ID EP208383
- DOI -
- Views 125
- Downloads 0
24-hour blood pressure profile in children with chronic pyelonephritis and chronic kidney disease stages I–III
Background. Blood pressure (BP) monitoring is important for the management of patients with chronic kidney disease (CKD), both for the conventional cardiovascular risk reduction and long-term preservation of kidney funct...
Cystatin C and chronic kidney disease in children
Background. Determination of diagnostically significant values of serum concentration of cystatin C in combination with the estimated glomerular filtration rate (GFR) gives clinicians an advantage in clearly differentiat...
Clinical case of successful treatment of Goodpasture syndrome with rituximab
.
Examination of a patient with renal pathology and idiopathic fever
Determination of causes of idiopathic fever is a fairly complicated process that in medical practice requires knowledge of the diagnostic algorithms for determining disease etiology accompanied by fever. For a nephrologi...
KDIGO 2017. Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease — Mineral and Bone Disorder (CKD-MBD)
.